Skip to main content

Day: January 28, 2025

Comstock Fuels and the BDO Zone Initiative Align to Accelerate Sustainable Fuel Development

OKLAHOMA CITY, Jan. 28, 2025 (GLOBE NEWSWIRE) — Comstock Inc. (NYSE American: LODE) today announced that its subsidiary, Comstock Fuels Corporation (“Comstock Fuels”), has joined the BDO Zone Strategic Partners Network, a group of leading companies in the bioenergy sector that help accelerate and de-risk biobased project development in BDO Zones. The BDO Zone Initiative is an internationally recognized standards-based assessment which certifies “regional readiness for bio-manufacturing,” creates global connections, and ignites an influx of clean energy opportunities. This groundbreaking collaboration combines the BDO Zone Initiative’s proven expertise and dedication in certifying “regional readiness for biomanufacturing” in biomass-rich regions with Comstock Fuels’ innovative renewable fuel solutions. This partnership will...

Continue reading

Unitil Schedules Fourth Quarter 2024 Earnings Release and Conference Call

HAMPTON, N.H., Jan. 28, 2025 (GLOBE NEWSWIRE) — Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release of its fourth quarter 2024 earnings after the market closes on February 10, 2025. Unitil will host its conference call and webcast on February 11, 2025 at 10:00 a.m. (ET) to review its results. Related presentation materials will be available before the call on the Company’s Investors page at investors.unitil.com. The conference call will be broadcast live in listen-only mode on the Company’s Investors page at investors.unitil.com. Interested parties may access dial information for the call by registering via web link here. An archive of the webcast will be available for one year on the website at investors.unitil.com. About Unitil Corporation Unitil Corporation provides energy for life by safely and reliably delivering...

Continue reading

Brazil Potash Executive Chairman Mayo Schmidt and Leadership Team Met With Amazonas State Governor, Wilson Lima, Mayor Thomé Neto, and the Mura Indigenous Council to Discuss Advancement of Autazes Potash Project

Strategic Discussion with Governor Lima Reinforces State-Level Support for Important Project to Brazil’s Agricultural Security Productive Engagements with State, Municipal and Indigenous Leadership Demonstrate Broad Community Support for Autazes Potash Project Development Meeting Follows Recent Strategic Advancements Including Indigenous MOU and Second Major Offtake MOUMANAUS, Brazil, Jan. 28, 2025 (GLOBE NEWSWIRE) — Brazil Potash Corp. (“Brazil Potash” or the “Company”) (NYSE-American: GRO), a company developing and constructing the largest potash fertilizer project in Brazil, today announced that Executive Chairman Mayo Schmidt, along with CEO Matt Simpson and Directors Brett Lynch and Peter Tagliamonte, recently met with Amazonas State Governor, Wilson Lima, Autazes Mayor Thomé Neto, and Coordinator of the Mura Indigenous...

Continue reading

MT Højgaard Holding A/S: MT Højgaard Danmark to build domicile for Grundfos

MT Højgaard Holding’s business unit MT Højgaard Danmark has entered into an agreement with Grundfos for the construction of a new 13,000 sqm domicile in Bjerringbro. In 2023, MT Højgaard Danmark entered into a preliminary contract for the assignment, which was conditional, i.a., on district planning changes. This contract is now unconditional. The new five-storey domicile will accommodate 660 employees, and the building will be part of a joint campus, which Grundfos is planning for the area. It is the ambition to ensure that the new domicile has as low a climate footprint as possible, and it is the plan to have the building certified at the DGNB Platin level while ensuring compliance with LEED Platinum requirements. The building is designed by AART architects with Niras acting as engineering consultant. The construction works will commence...

Continue reading

Lantheus to Acquire Evergreen Theragnostics for Upfront Payment of $250 Million to Drive Strategic Evolution into Fully Integrated Radiopharmaceutical Leader

Advances radiopharmaceutical leadership with addition of scalable manufacturing infrastructure and end-to-end clinical development capabilities Adds OCTEVY™, a registrational-stage diagnostic asset, targeting neuroendocrine tumors that is complementary to Lantheus’ therapeutic agent, PNT2003 Expands oncology radiopharmaceutical pipeline with multiple clinical and pre-clinical theranostic pairs Company reaffirms Full-Year and Fourth Quarter, 2024 financial guidance Company to host conference call on January 28, 2025, at 8:30 AM ET BEDFORD, Mass., Jan. 28, 2025 (GLOBE NEWSWIRE) — Lantheus Holdings, Inc. (“Lantheus” or the “Company”) (NASDAQ: LNTH), the leading radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver better patient outcomes, today announced a definitive...

Continue reading

Provident Financial Holdings Reports Second Quarter of Fiscal Year 2025 Results

Net Income of $872,000 in the December 2024 Quarter, Down 54% from the Sequential Quarter and 59% from the Comparable Quarter Last Year Net Interest Margin of 2.91% in the December 2024 Quarter, Up Seven Basis Points from the Sequential Quarter and 13 Basis Points from the Comparable Quarter Last Year Loans Held for Investment of $1.05 Billion at December 31, 2024, Unchanged from June 30, 2024 Total Deposits of $867.5 Million at December 31, 2024, Down 2% from June 30, 2024 Non-Performing Assets to Total Assets Ratio of 0.20% at December 31, 2024, Unchanged from June 30, 2024 Non-Interest Expenses Remain Well Controlled RIVERSIDE, Calif., Jan. 28, 2025 (GLOBE NEWSWIRE) — Provident Financial Holdings, Inc. (“Company”), NASDAQ GS: PROV, the holding company for Provident Savings Bank, F.S.B. (“Bank”), today announced earnings for...

Continue reading

Publication of eQ Plc’s 2024 financial statements release and invitation to result presentation

eQ Plc Investor news 28 January 2025, at 1:30 p.m. eQ Plc will publish its 2024 financial statements release on Tuesday 4 February 2025 at around 8:00 a.m. eQ will present the 2024 result to press, investors and analysts in a press conference to be held on 4 February 2025 at 11:00 a.m. The press conference will held at eQ’s head office in Helsinki, address Aleksanterinkatu 19, 5th floor, 00100 Helsinki and it is also possible to participate via webcast. The webcast participation requires a registration. The press conference will be held in Finnish. The presentation material can be viewed at eQ’s website after the press conference has begun. To join the press conference, please register with Nicolina.Zilliacus@eq.fi. eQ Plc Additional information: Antti Lyytikäinen, CFO, tel. +358 9 6817 8741 Distribution: Nasdaq Helsinki,...

Continue reading

Form 8.3 – [LOUNGERS PLC – 27 01 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary Clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LOUNGERS PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

Form 8.3 – [LEARNING TECHNOLOGIES GROUP PLC – 27 01 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree LEARNING TECHNOLOGIES GROUP PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date...

Continue reading

Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence

Conduit is planning how to effectively integrate an advanced platform-driven approach powered by artificial intelligence and cybernetics to expedite drug development, while continuing to advance its portfolio of proprietary assets to clinic.NAPLES, Fla. and CAMBRIDGE, United Kingdom, Jan. 28, 2025 (GLOBE NEWSWIRE) — Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit” or the “Company”), today is pleased to announce the completion of the first phase of its strategic collaboration with Sarborg Limited. This partnership was initiated in December 2024 to integrate an advanced artificial intelligence and cybernetics technology (“AI”) into the Company’s operations, marking a transformative step in how Conduit would develop and deliver drug development. By leveraging AI, the Company is seeking to streamline drug repurposing, accelerate...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.